Table I. Demographic and immunologic profile of HIV-1-infected individuals.
Patient number | Age (y) | Gender | Ethnicity | Estimateda time of infection at biopsy (months) | Plasma HIV-1 RNA at time of biopsyb (copies/ml) | CD4 count at time of biopsy (cells/μl) | Serum gp140 binding ELISA (OD) |
---|---|---|---|---|---|---|---|
1 | 26 | Male | Hispanic | 14 | 1118 | 777 | 0.428 |
2 | 34 | Male | Hispanic | 16-28 | 14200 | 460 | 0.816 |
3 | 31 | Male | Black | >120 | 164 | 714 | 2.461 |
4 | 26 | Female | Black | 19 | 2549 | 479 | 0.95 |
5 | 44 | Male | White | >96 | 3739 | 403 | 2.593 |
6 | 29 | Female | Hispanic | >101 | 1562 | 434 | 2.091 |
7 | 28 | Male | Hispanic | 27 | 20964 | 397 | 3.189 |
8 | 23 | Male | Hispanic | 23 | 19156 | 875 | 2.989 |
Estimated from clinical history taken at screening visit.
All were ART-naïve, except #5 and #6 discontinued ART 35 and 75 months prior to study, respectively.